Wednesday, August 23, 2017 3:44:41 AM
Step back and look again
Take a wider view on this. It's too easy to get lost in the daily fears and concerns and miss the big picture.
The encapsulation of cells is the next frontier in medicine, especially stem cells.
We own licenses to the best encapsulation technology in the world for cancer diabetes and cabbinoids. It's unique. It's bioinert, retrievable, avoids fibrosis and can be frozen to enable distribution and commercializations
There's nothing else like it. Cells based on algae can't be frozen and viacytes capsule must be surgically implanted and causes a fibrotic reaction.
Cell based treatments are the future and big pharmacyte knows this. Search novo nordisk and J&j + encapsulation if you don't believe me. Major foundations like juvenile diabetes also believe encapsulation is the best hope for a cure for diabetes.
We have a way of directly attacking tumors right beside them and without side effects. Amazing. No side effects.
We have a way of putting insulin creating cells into the body to cure diabetes. Amazing. Trials with ciab and rats and a pancreatic cell showed normal insulin production for six months. Mellingen cells promise to be even hardier and more effective.
We are creating our cell banks for a pivotal clinical trial in pancreatic cancer. Pivotal. Agreed by the FDA. Expected to be ready in third quarter.
We have an amazing team of world class doctors and oncologists involved and a consortium of the world's best advising the progress of our technology in cancer and diabetes.
Recent clinical results for ascites showed a complete tumor remission after several doses of ifosfamide. this is a stunning result and shows how much the company's encapsulation technology has
improved over the last years.
Johnson and Johnson, novo nordisk and many diabetes organizations see cell encapsulation as the biggest hope for a cure for diabetes. The problem has been the immune system attacking those caps.
Pharmacyte and ciab have the only commercially viable solution which doesn't involve implants or surgery and all the problems associated with that. Because our encapsulation can be frozen and transported. It's unique.
Of course big pharma will want this? The question is how much will they pay and can kw salmon and gunzberg start a bidding war? After the PIVOTAL ind for pancreatic cancer has been accepted by the FDA we will be ready for funding. Talks are continuing to take place for funding with millions expected for us.
We are months away from our pivotal FDA agreed ind.
How much would an injections cure for diabetes that lasts at least two years be worth? Hundreds of billions in insulin monitoring and care for the severe effects of diabetes would be saved. Tens of billions a year at least for a solution to the worlds fastest growing illness
It's a technology whose time has come.
The patient and methodical pre ind preparations, previous clinical results and the caliber of doctors working on the planning for the trial resulted in the FDA agreeing to a pivotal trial. This is an exceptional result and shows how carefully the pharmacyte team are progressing.
A game changing technology which many will find hard to accept because of the successes and changes it will bring.
Sure Trader - Start Trading Stocks & Options with only $500
Recent PMCB News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/13/2024 08:37:40 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 07/29/2024 08:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:59:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:58:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:58:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:58:35 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 08:05:04 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 05/30/2024 08:05:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:40:20 PM
- PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease • Business Wire • 05/21/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:38:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 02:56:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 10:25:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:00:10 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/22/2023 09:00:15 PM
- PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc. • Business Wire • 11/15/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:25:09 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM